Is MRD up or down today?
MRD is up 0.76% today, last at 329.74. This stock moved +0.76% versus the prior close.
MRD · MRD
MRD (MRD) is trading at 329.74, up 0.76% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 4 headlines skew mostly positive. Earnings and Guidance themes dominated coverage.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
MRD is up 0.76% today, last at 329.74. This stock moved +0.76% versus the prior close.
Over the past 7 days, 4 headlines skew mostly positive. Earnings and Guidance themes dominated coverage. Dominant story: ADPT: MRD revenue and volumes surged, guidance was raised, and strategic separation advanced - TradingView (1 source, bullish) RSI unavailable Price sits at 50% of its 52-week range Social (demo): 38% of recent mentions lean bullish — social mood is cautious.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: MRD
49/ 100 index
-26.9% vs start of window
Based on 11,213 mentions over 30d
ADPT: MRD revenue and volumes surged, guidance was raised, and strategic separation advanced - TradingView
Adaptive Biotechnologies (Nasdaq: ADPT) boosts MRD 2026 guidance after Q2 revenue hits $71.6M - Stock Titan
Adaptive Biotechnologies earnings up next: Can MRD offset revenue dip? - Investing.com
How Raised MRD Revenue Guidance And Upgraded Earnings At Adaptive Biotechnologies (ADPT) Has Changed Its Investment Story - simplywall.st
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion - Investing.com